Literature DB >> 3970592

Refractory massive pleural effusion in systemic lupus erythematosus treated with talc poudrage.

J L Kaine.   

Abstract

The case of a 31-year-old black male is presented with recurrent pleural effusion secondary to active SLE. Treatment with corticosteroids, azathioprine, plaquenil, and tetracycline pleural sclerosis was unsuccessful. Disease control was finally achieved by pleural talc poudrage.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3970592      PMCID： PMC1001569          DOI： 10.1136/ard.44.1.61

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  7 in total

1.  Reduction of pleural fluid complement activity in patients with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  M M Glovsky; J S Louie; W H Pitts; A Alenty
Journal:  Clin Immunol Immunopathol       Date:  1976-07

2.  The role of immune complexes in the pathogenesis of pleural effusions.

Authors:  B S Andrews; N S Arora; M F Shadforth; S K Goldberg; J S Davis
Journal:  Am Rev Respir Dis       Date:  1981-08

3.  Pleural fluid complement, complement conversion, and immune complexes in immunologic and nonimmunologic diseases.

Authors:  G G Hunder; F C McDuffie; K A Huston; L R Elveback; N G Hepper
Journal:  J Lab Clin Med       Date:  1977-12

4.  Acute pulmonary complications in systemic lupus erythematosus. Immunofluorescence and light microscopic study.

Authors:  L P Pertschuk; L F Moccia; Y Rosen; H Lyons; C M Marino; A A Rashford; C M Wollschlager
Journal:  Am J Clin Pathol       Date:  1977-11       Impact factor: 2.493

5.  Immune complexes and other laboratory features of pleural effusions: a comparison of rheumatoid arthritis, systemic lupus erythematosus, and other diseases.

Authors:  J T Halla; R E Schrohenloher; J E Volanakis
Journal:  Ann Intern Med       Date:  1980-06       Impact factor: 25.391

6.  Immunopathologic studies of pneumonitis in systemic lupus erythematosus.

Authors:  T Inoue; Y Kanayama; A Ohe; N Kato; T Horiguchi; M Ishii; K Shiota
Journal:  Ann Intern Med       Date:  1979-07       Impact factor: 25.391

7.  Chronic pleurisy in systemic lupus erythematosus treated with pleurectomy.

Authors:  R Bell; D S Lawrence
Journal:  Br J Dis Chest       Date:  1979-07
  7 in total
  6 in total

Review 1.  Pleuropulmonary manifestations of systemic lupus erythematosus.

Authors:  M P Keane; J P Lynch
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

2.  Refractory massive pleural effusion in systemic lupus erythematosus treated by pleurectomy.

Authors:  J S Elborn; P Conn; S D Roberts
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

3.  Pleuritis and pleural effusion as the initial presentation of systemic lupus erythematous in a 23-year-old woman.

Authors:  Kong-Sang Wan
Journal:  Rheumatol Int       Date:  2008-05-22       Impact factor: 2.631

4.  Steroid resistant pleural effusion in systemic lupus erythematosus treated with tetracycline pleurodesis.

Authors:  M H Gilleece; C C Evans; R C Bucknall
Journal:  Ann Rheum Dis       Date:  1988-12       Impact factor: 19.103

Review 5.  Why is a paediatric respiratory specialist integral to the paediatric rheumatology clinic?

Authors:  Manisha Ramphul; Kathy Gallagher; Kishore Warrier; Sumit Jagani; Jayesh Mahendra Bhatt
Journal:  Breathe (Sheff)       Date:  2020-12

Review 6.  Clinical perspective and practices on pleural effusions in chronic systemic inflammatory diseases.

Authors:  Xuan Yao; Megat Abd Hamid; Anand Sundaralingam; Alice Evans; Roshan Karthikappallil; Tao Dong; Najib M Rahman; Nikolaos I Kanellakis
Journal:  Breathe (Sheff)       Date:  2020-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.